Home
/
USANA HEALTH SCIENCES INC
/
Financials
/
Quarterly
USANA HEALTH SCIENCES INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that USANA HEALTH SCIENCES INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2020
Sep 26, 2020
$298.51M
Nov 3, 2020
Q2
2020
Jun 27, 2020
$258.99M
Aug 4, 2020
Q1
2020
Mar 28, 2020
$266.62M
May 5, 2020
Q3
2020
Sep 28, 2019
$260.60M
Nov 3, 2020
Q2
2020
Jun 29, 2019
$256.02M
Aug 4, 2020
Q1
2020
Mar 30, 2019
$272.99M
May 5, 2020
Q3
2019
Sep 29, 2018
$296.77M
Nov 5, 2019
Q2
2019
Jun 30, 2018
$301.46M
Aug 6, 2019
Q1
2019
Mar 31, 2018
$292.00M
May 7, 2019
Q3
2018
Sep 30, 2017
$261.77M
Nov 7, 2018
Q2
2018
Jul 1, 2017
$257.06M
Aug 8, 2018
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 27, 2025
$213.67M
Nov 5, 2025
Q2
2025
Jun 28, 2025
$235.85M
Aug 5, 2025
Q1
2025
Mar 29, 2025
$249.54M
May 6, 2025
Q3
2025
Sep 28, 2024
$200.22M
Nov 5, 2025
Q2
2025
Jun 29, 2024
$212.87M
Aug 5, 2025
Q1
2025
Mar 30, 2024
$227.80M
May 6, 2025
Q3
2024
Sep 30, 2023
$213.37M
Nov 5, 2024
Q2
2024
Jul 1, 2023
$238.20M
Aug 6, 2024
Q1
2024
Apr 1, 2023
$248.36M
May 7, 2024
Q3
2023
Oct 1, 2022
$233.30M
Nov 7, 2023
Q2
2023
Jul 2, 2022
$264.47M
Aug 8, 2023
Q1
2023
Apr 2, 2022
$272.87M
May 9, 2023
Q3
2022
Oct 2, 2021
$274.35M
Nov 8, 2022
Q2
2022
Jul 3, 2021
$336.84M
Aug 9, 2022
Q1
2022
Apr 3, 2021
$307.98M
May 11, 2022
Q3
2022
Sep 26, 2020
$298.51M
Nov 10, 2021
Q2
2022
Jun 27, 2020
$258.99M
Aug 11, 2021
Q1
2021
Mar 28, 2020
$266.62M
May 11, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 27, 2025
($6.52M)
Nov 5, 2025
Q2
2025
Jun 28, 2025
$9.66M
Aug 5, 2025
Q1
2025
Mar 29, 2025
$9.40M
May 6, 2025
Q3
2025
Sep 28, 2024
$10.61M
Nov 5, 2025
Q2
2025
Jun 29, 2024
$10.43M
Aug 5, 2025
Q1
2025
Mar 30, 2024
$16.54M
May 6, 2025
Q3
2024
Sep 30, 2023
$11.35M
Nov 5, 2024
Q2
2024
Jul 1, 2023
$17.29M
Aug 6, 2024
Q1
2024
Apr 1, 2023
$18.38M
May 7, 2024
Q3
2023
Oct 1, 2022
$14.93M
Nov 7, 2023
Q2
2023
Jul 2, 2022
$19.16M
Aug 8, 2023
Q1
2023
Apr 2, 2022
$22.47M
May 9, 2023
Q3
2022
Oct 2, 2021
$27.33M
Nov 8, 2022
Q2
2022
Jul 3, 2021
$38.23M
Aug 9, 2022
Q1
2022
Apr 3, 2021
$30.62M
May 11, 2022
Q3
2022
Sep 26, 2020
$30.51M
Nov 10, 2021
Q2
2022
Jun 27, 2020
$27.98M
Aug 11, 2021
Q1
2021
Mar 28, 2020
$26.55M
May 11, 2021
Q3
2020
Sep 28, 2019
$24.22M
Nov 3, 2020
Q2
2020
Jun 29, 2019
$21.38M
Aug 4, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 27, 2025
$1.22M
Nov 5, 2025
Q2
2025
Jun 28, 2025
$16.72M
Aug 5, 2025
Q1
2025
Mar 29, 2025
$15.67M
May 6, 2025
Q3
2025
Sep 28, 2024
$15.60M
Nov 5, 2025
Q2
2025
Jun 29, 2024
$17.84M
Aug 5, 2025
Q1
2025
Mar 30, 2024
$24.67M
May 6, 2025
Q3
2024
Sep 30, 2023
$17.61M
Nov 5, 2024
Q2
2024
Jul 1, 2023
$24.40M
Aug 6, 2024
Q1
2024
Apr 1, 2023
$26.85M
May 7, 2024
Q3
2023
Oct 1, 2022
$22.63M
Nov 7, 2023
Q2
2023
Jul 2, 2022
$29.37M
Aug 8, 2023
Q1
2023
Apr 2, 2022
$33.07M
May 9, 2023
Q3
2022
Oct 2, 2021
$40.77M
Nov 8, 2022
Q2
2022
Jul 3, 2021
$53.72M
Aug 9, 2022
Q1
2022
Apr 3, 2021
$44.20M
May 11, 2022
Q3
2022
Sep 26, 2020
$45.36M
Nov 10, 2021
Q2
2022
Jun 27, 2020
$39.59M
Aug 11, 2021
Q1
2021
Mar 28, 2020
$39.01M
May 11, 2021
Q3
2020
Sep 28, 2019
$35.46M
Nov 3, 2020
Q2
2020
Jun 29, 2019
$31.16M
Aug 4, 2020